To download the poster, click here

 **Please note that an Eventbrite fee is added when registering online  and paying by credit/debit/paypal.  To avoid this fee, register using  the below option

​​​​​​​​​Instructor: Michael Verbora, MBA, MD
Location: Online Live Stream Event

Early Bird Cost: $175 CAD + 13% HST (=$197.75) by May 12, 2020

​Regular Cost: $200 CAD = 13% HST (=$226) after May 12, 2020

​**All prices are in CAD$. American Patrons - your dollar goes further! $1 CAD = $0.70 USD (as of March 25, 2020 - check online for current exchange rate) 

REGISTRATION DEADLINE: June 3, 2020 at 12 pm

* For information about Group Rates and Discounts 
click here.

1) To pay with CREDIT CARD or PAYPAL: 
click here **to register online via Eventbrite for this option (see highlighted note below)

​​​​​​​​​​​​​​Workshop Description

Many counsellors and clinicians are hearing from their clients about the benefits of cannabis and/or CBD for mental health and physical health conditions – some who have experienced rapid improvement in long-term conditions that did not respond to traditional therapies/medications. They wonder - if such results were possible for these clients, should they be discussing cannabis/CBD therapy with other clients who have similar conditions?

At the same time, clinicians have heard about the risks of cannabis, the increase in addiction rates and cannabis-induced psychosis, the role of cannabis in the onset of symptoms of schizophrenia, and the detrimental effects of cannabis on the developing brain.  With such contradictory information about the risks and benefits, they don’t know which clients could benefit and which could experience harm. 

This workshop is designed to answer the questions that counsellors and clinicians have, in order to help them better educate their clients. Questions such as…

  • Who benefits from cannabis/CBD and what conditions is it known to help?
  • Is it safe?
  • For whom is cannabis/CBD contraindicated?
  • What about children, youth, people with serious mental illnesses like schizophrenia?
  • Who is at risk for cannabis addiction?
  • Differences between CBD and THC
  • Why are some people prescribed CBD on its own whereas others are prescribed a THC/CBD mix?
  • What are the typical doses recommended for different conditions?
  • Are there Health Canada regulated clinics dispensing cannabis/CBD?
  • Where to refer clients who may benefit from cannabis/CBD treatment

Dr. Michael Verbora, a practising physician and leader in this field, will provide researched-based information and answer your questions. He will focus on the various aspects of cannabis, including the way cannabinoids interact in the human body and the changes in physical and mental health when consuming cannabinoids. He will present the evidence known to date and the emerging science behind some of the benefits of cannabis & CBD therapy. The risks and adverse events seen with cannabis will also be discussed with a focus on the effects on mental health such as depression, anxiety and substance dependence.

This workshop will provide an in-depth look at cannabis from a balanced, evidence-based perspective that takes into account its historical applications, modern day use and the various reasons for the resurgence in popularity of this therapy. Lastly, the course will walk you through some of the legal channels for access and present a global overview of the cannabis landscape.

You will receive:

An electronic handout package emailed prior to the workshop and a workshop certificate afterwards.  Login details and instructions will be emailed in advance of the workshop.

2) To pay with EMAIL MONEY TRANSFER (CAD bank accts only): 

​     click here ​​to access the google form and follow the instructions on the form.

** Please note: Due to COVID-19 we are not accepting cheque registrations at this time in order to protect our staff, as our mailbox is off-site.

Cannabis & CBD Update:
What Counsellors and Clinicians Need to Know


June 5, 2020, 9:00 am - 4:00 pm EDT

Cancellation Policy

​​An administrative fee of $50 will be charged for all cancellations.  Cancellation 14 or more days prior to the workshop date – receive a refund, less $50 administration fee. Cancellation less than 14 days prior to the workshop date – receive a credit, less $50 administration fee, to be applied to a future workshop. No credit or refund will be issued if you do not notify us in advance of the workshop date. You may transfer your registration to another individual at no extra cost. In this case, please notify Mission: Empowerment of the name of the alternate person. The organizers reserve the right to cancel the event due to instructor illness, extreme weather, under-enrollment or other unforeseen circumstances. If a workshop is cancelled, any registration payment will be returned in full. Liability is limited to a refund of workshop/live-stream fees only.

About the Presenter

Dr. Michael Verbora, MBA, MD, is an internationally recognized expert on medical cannabis. Michael earned an MBA from the University of Windsor’s Odette School of Business in 2009 and an M.D. from Schulich School of Medicine at Western University in 2013, before entering a Family Practice residency at the University of Toronto. A member of the Canadian Consortium for the Investigation of Cannabinoids, Doctors for Responsible Access and the Canadian Pain Society, he has completed over 4,000 cannabinoid therapy consultations. He previously served as medical director for Canabo Medical Corp which operates over twenty clinics across Canada and now serves as Chief Medical Officer of Aleafia, a Canadian LP.

Michael remains focused in clinic work as a student health physician at Seneca College and as a cannabinoid clinician. He serves as a delegate on the Ontario Medical Association and currently sits on the executive of the Ontario Medical Association Cannabis Interest Group. In addition, Michael recently joined the McMaster University School of Medicine as an Assistant Professor.

To date, Michael has given over one hundred presentations on cannabinoid therapy, including internationally to government, parliament and regulators.